Literature DB >> 21345366

Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia.

Amy F T Arnsten1.   

Abstract

The symptoms of schizophrenia involve profound dysfunction of the prefrontal cortex (PFC). PFC networks create our "mental sketch pad", and PFC dysfunction contributes to symptoms such as cognitive deficits, thought disorder, delusions and hallucinations. Neuropathological studies of schizophrenia have shown marked loss of dendritic spines in deep layer III, the sublayer where PFC microcircuits reside. The microcircuits consist of recurrent excitatory pyramidal cell networks that interconnect on spines, and excite each other via NMDA receptor signaling. The pyramidal cell persistent firing is sculpted by lateral inhibition from GABAergic basket and chandelier cells, thus creating tuned, persistent firing needed for accurate representational knowledge (i.e., working memory). The strength of pyramidal cell network connections is markedly and flexibly altered by intracellular signaling pathways in dendritic spines, a process called dynamic network connectivity (DNC). DNC proteins such as HCN channels are concentrated on dendritic spines in deep layer III. Under optimal conditions, network inputs to pyramidal cells are strengthened by noradrenergic alpha-2A inhibition of cAMP-HCN channel signaling, and sculpted by dopamine D1-cAMP-HCN channel weakening of inappropriate inputs. However, with stress exposure, high levels of cAMP-HCN channel signaling produces a collapse in network firing. With chronic stress exposure, spines reduce in size and are lost, and this process involves increased PKC signaling. Importantly, molecules that normally strengthen PFC networks connections and/or reverse the stress response, are often genetically altered in schizophrenia. As exposure to stress is a key factor in the precipitation of schizophrenic symptoms, these dysregulated signaling pathways in deep layer III may interact with already vulnerable circuitry to cause spine loss and the descent into illness.
Copyright © 2011 ISDN. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21345366      PMCID: PMC3115784          DOI: 10.1016/j.ijdevneu.2011.02.006

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  105 in total

1.  Spatial and intracellular relationships between the alpha7 nicotinic acetylcholine receptor and the vesicular acetylcholine transporter in the prefrontal cortex of rat and mouse.

Authors:  A M Duffy; P Zhou; T A Milner; V M Pickel
Journal:  Neuroscience       Date:  2009-04-15       Impact factor: 3.590

2.  Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory.

Authors:  S G Rao; G V Williams; P S Goldman-Rakic
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

3.  A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists.

Authors:  Jerry J Buccafusco; Alvin V Terry
Journal:  Biochem Pharmacol       Date:  2009-07-03       Impact factor: 5.858

4.  A brain mechanism for facilitation of insight by positive affect.

Authors:  Karuna Subramaniam; John Kounios; Todd B Parrish; Mark Jung-Beeman
Journal:  J Cogn Neurosci       Date:  2009-03       Impact factor: 3.225

5.  Psychosocial stress reversibly disrupts prefrontal processing and attentional control.

Authors:  C Liston; B S McEwen; B J Casey
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-12       Impact factor: 11.205

6.  Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals.

Authors:  Daqiang Sun; Lisa Phillips; Dennis Velakoulis; Alison Yung; Patrick D McGorry; Stephen J Wood; Theo G M van Erp; Paul M Thompson; Arthur W Toga; Tyrone D Cannon; Christos Pantelis
Journal:  Schizophr Res       Date:  2009-01-12       Impact factor: 4.939

7.  A history of corticosterone exposure regulates fear extinction and cortical NR2B, GluR2/3, and BDNF.

Authors:  Shannon L Gourley; Alexia T Kedves; Peter Olausson; Jane R Taylor
Journal:  Neuropsychopharmacology       Date:  2008-08-20       Impact factor: 7.853

8.  Mapping the regulator of G protein signaling 4 (RGS4): presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortex.

Authors:  Constantinos D Paspalas; Lynn D Selemon; Amy F T Arnsten
Journal:  Cereb Cortex       Date:  2009-01-19       Impact factor: 5.357

9.  Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress.

Authors:  K H Nuechterlein; M E Dawson; M Gitlin; J Ventura; M J Goldstein; K S Snyder; C M Yee; J Mintz
Journal:  Schizophr Bull       Date:  1992       Impact factor: 9.306

10.  Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex.

Authors:  Huai-Xing Wang; Wen-Jun Gao
Journal:  Neuropsychopharmacology       Date:  2009-02-25       Impact factor: 7.853

View more
  77 in total

1.  Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models.

Authors:  Gregory J Digby; Meredith J Noetzel; Michael Bubser; Thomas J Utley; Adam G Walker; Nellie E Byun; Evan P Lebois; Zixiu Xiang; Douglas J Sheffler; Hyekyung P Cho; Albert A Davis; Natali E Nemirovsky; Sarah E Mennenga; Bryan W Camp; Heather A Bimonte-Nelson; Jacob Bode; Kimberly Italiano; Ryan Morrison; J Scott Daniels; Colleen M Niswender; M Foster Olive; Craig W Lindsley; Carrie K Jones; P Jeffrey Conn
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

2.  Respiratory, metabolic and cardiac functions are altered by disinhibition of subregions of the medial prefrontal cortex.

Authors:  Sarah F Hassan; Jennifer L Cornish; Ann K Goodchild
Journal:  J Physiol       Date:  2013-09-16       Impact factor: 5.182

Review 3.  Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction.

Authors:  Laura L Giacometti; Jacqueline M Barker
Journal:  Brain Res       Date:  2019-08-14       Impact factor: 3.252

4.  Knockdown of phospholipase C-β1 in the medial prefrontal cortex of male mice impairs working memory among multiple schizophrenia endophenotypes.

Authors:  Seong-Wook Kim; Misun Seo; Duk-Soo Kim; Moonkyung Kang; Yeon-Soo Kim; Hae-Young Koh; Hee-Sup Shin
Journal:  J Psychiatry Neurosci       Date:  2015-03       Impact factor: 6.186

5.  Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior.

Authors:  Rolf T Hansen; Marco Conti; Han-Ting Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

6.  Prefrontal Cortical Inactivations Decrease Willingness to Expend Cognitive Effort on a Rodent Cost/Benefit Decision-Making Task.

Authors:  Jay G Hosking; Paul J Cocker; Catharine A Winstanley
Journal:  Cereb Cortex       Date:  2015-01-16       Impact factor: 5.357

7.  Assessment of mental stress effects on prefrontal cortical activities using canonical correlation analysis: an fNIRS-EEG study.

Authors:  Fares Al-Shargie; Tong Boon Tang; Masashi Kiguchi
Journal:  Biomed Opt Express       Date:  2017-04-19       Impact factor: 3.732

8.  Cognitive control and associated neural correlates in adults with spina bifida myelomeningocele.

Authors:  Ashley L Ware; Paulina A Kulesz; Jenifer Juranek; Paul T Cirino; Jack M Fletcher
Journal:  Neuropsychology       Date:  2017-02-16       Impact factor: 3.295

9.  Preliminary evidence of neuropathology in nonhuman primates prenatally exposed to maternal immune activation.

Authors:  Ruth K Weir; Reihaneh Forghany; Stephen E P Smith; Paul H Patterson; A Kimberly McAllister; Cynthia M Schumann; Melissa D Bauman
Journal:  Brain Behav Immun       Date:  2015-03-24       Impact factor: 7.217

10.  Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy.

Authors:  Shelli R Kesler; Christa Watson; Della Koovakkattu; Clement Lee; Ruth O'Hara; Misty L Mahaffey; Jeffrey S Wefel
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.